UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants

Clinical infectious diseases, 2015-12, Vol.61 (12), p.1862-1870

2015

Volltextzugriff (PDF)

The role of internalised HIV stigma in disclosure of maternal HIV serostatus to children perinatally HIV‐exposed but uninfected: a prospective study in the United States

Journal of the International AIDS Society, 2023-10, Vol.26 (S4), p.e26167-n/a

2023

Volltextzugriff (PDF)

Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis

Infectious disease clinics of North America, 2018-03, Vol.32 (1), p.91-101

2018

Volltextzugriff (PDF)

Surviving and Thriving-Shifting the Public Health Response to HIV-Exposed Uninfected Children: Report of the 3rd HIV-Exposed Uninfected Child Workshop

Frontiers in pediatrics, 2018-05, Vol.6, p.157-157

2018

Volltextzugriff (PDF)

Factors associated with internalized HIV-related stigma among biological mothers living with HIV enrolled in a US cohort study

AIDS care, 2024-02, Vol.36 (2), p.220-226

2024

Volltextzugriff (PDF)

Evaluating the association of antiretroviral therapy and immune status with hypertensive disorders of pregnancy among people with HIV

AIDS (London), 2023-09, Vol.37 (11), p.1715-1723

2023

Volltextzugriff (PDF)

Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States

The New England journal of medicine, 2022-09, Vol.387 (9), p.799-809

2022

Volltextzugriff (PDF)

Sexually Transmitted Infections in Pregnant People With Human Immunodeficiency Virus: Temporal Trends, Demographic Correlates, and Association With Preterm Birth

Clinical infectious diseases, 2022-12, Vol.75 (12), p.2211-2218

2022

Volltextzugriff (PDF)

Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children

The Journal of infectious diseases, 2022-12, Vol.226 (12), p.2069-2078

2022

Volltextzugriff (PDF)

Association of Fatty Acid Signatures with HIV Viremia in Pregnancy

AIDS research and human retroviruses, 2024-04, Vol.40 (4), p.257

2024

Volltextzugriff (PDF)

Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children

Clinical infectious diseases, 2022-08, Vol.75 (2), p.347-355

2022

Volltextzugriff (PDF)

Combination Antiretroviral Therapy and Hypertensive Disorders of Pregnancy

Obstetrics and gynecology (New York. 1953), 2019-12, Vol.134 (6), p.1205

2019

Volltextzugriff (PDF)

Gestational weight gain in persons with HIV in the United States

AIDS (London), 2023-05, Vol.37 (6), p.883-893

2023

Volltextzugriff (PDF)

Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected

AIDS (London), 2020-07, Vol.34 (9), p.1377-1387

2020

Volltextzugriff (PDF)

Dynamics of the resting CD4+ T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age

AIDS (London), 2012-07, Vol.26 (12), p.1483-1490

2012

Volltextzugriff (PDF)

Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine

The New England journal of medicine, 2018-04, Vol.378 (17), p.1593-1603

2018

Volltextzugriff (PDF)

Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e744-e747

2023

Volltextzugriff (PDF)

Impact of CYP2B6 genotype, tuberculosis therapy, and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age

AIDS (London), 2022-03, Vol.36 (4), p.525-532

2022

Volltextzugriff (PDF)

Health Insurance Coverage, Clinical Outcomes, and Health-Related Quality of Life Among Youth Born to Women Living With HIV

Journal of acquired immune deficiency syndromes (1999), 2023-01, Vol.92 (1), p.6

2023

Volltextzugriff (PDF)

High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali

The Pediatric infectious disease journal, 2017-11, Vol.36 (11), p.e258-e263

2017

Volltextzugriff (PDF)

Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors

Antimicrobial Agents and Chemotherapy, 2008-09, Vol.52 (9), p.3276-3283

2008

Volltextzugriff (PDF)

Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood

Journal of clinical pharmacology, 2018-12, Vol.58 (12), p.1604-1617

2018

Volltextzugriff (PDF)

Pharmacokinetics and safety of maraviroc in neonates

AIDS (London), 2021-03, Vol.35 (3), p.419-427

2021

Volltextzugriff (PDF)

In utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns

AIDS (London), 2021-08, Vol.35 (10), p.1525-1535

2021

Volltextzugriff (PDF)

Repeat Pregnancies Among US Women Living With HIV in the SMARTT Study: Temporal Changes in HIV Disease Status and Predictors of Preterm Birth

Journal of acquired immune deficiency syndromes (1999), 2020-11, Vol.85 (3), p.346

2020

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(111)
Buchkapitel
(1)

Sprache

Englisch
(112)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants

The role of internalised HIV stigma in disclosure of maternal HIV serostatus to children perinatally HIV‐exposed but uninfected: a prospective study in the United States

Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis

Surviving and Thriving-Shifting the Public Health Response to HIV-Exposed Uninfected Children: Report of the 3rd HIV-Exposed Uninfected Child Workshop

Factors associated with internalized HIV-related stigma among biological mothers living with HIV enrolled in a US cohort study

Evaluating the association of antiretroviral therapy and immune status with hypertensive disorders of pregnancy among people with HIV

Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States

Sexually Transmitted Infections in Pregnant People With Human Immunodeficiency Virus: Temporal Trends, Demographic Correlates, and Association With Preterm Birth

Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children

Association of Fatty Acid Signatures with HIV Viremia in Pregnancy

Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children

Combination Antiretroviral Therapy and Hypertensive Disorders of Pregnancy

Gestational weight gain in persons with HIV in the United States

Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected

Dynamics of the resting CD4+ T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age

Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine

Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life

Impact of CYP2B6 genotype, tuberculosis therapy, and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age

Health Insurance Coverage, Clinical Outcomes, and Health-Related Quality of Life Among Youth Born to Women Living With HIV

High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali

Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors

Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood

Pharmacokinetics and safety of maraviroc in neonates

In utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns

Repeat Pregnancies Among US Women Living With HIV in the SMARTT Study: Temporal Changes in HIV Disease Status and Predictors of Preterm Birth

Suchergebnisse filtern